Equillium EQ
NASDAQ EQ
$2.21 -0.01 (-0.45%)
At close: Sep 4, 2026 · 4:00 PM EDT

Equillium (EQ) Net Equity Issued and Repurchased (2020 - 2025)

Equillium (EQ) posted quarterly Net Equity Issued and Repurchased of -$137000.0 for Q4 2025, down 298.55% year-over-year from $69000.0 in Q4 2024, and down 115.22% quarter-over-quarter from $900000.0 in Q3 2025.

Analysis

Equillium (EQ) Net Equity Issued and Repurchased (2020 - 2025) Analysis & Trends

Equillium (EQ) has reported Net Equity Issued and Repurchased for 4 consecutive years, with -$137000.0 the latest figure, recorded in Q4 2025.

  • In Q4 2025, Net Equity Issued and Repurchased fell 298.55% year-over-year to -$137000.0; the TTM figure through Dec 2025 stood at $818000.0 (down 95.91% YoY), while the FY2025 annual figure was $682000.0, up 326.25% from the prior year.
  • Net Equity Issued and Repurchased eased to -$137000.0 in Q4 2025 per EQ's latest filing, from $900000.0 in the prior quarter.
  • Across five years, Net Equity Issued and Repurchased topped out at $55.0 million in Q1 2025 and bottomed at -$54.9 million in Q2 2025.
  • Historically, Net Equity Issued and Repurchased has averaged $4.4 million across 3 years, with a median of $900000.0 in 2025.
  • Annual changes were most pronounced in 2021 — Net Equity Issued and Repurchased jumped 1190.32% — and 2025, when it sank 298.55%.
  • Equillium's Net Equity Issued and Repurchased stood at $19.9 million in 2021, then plunged by 99.65% to $69000.0 in 2024, then tumbled by 298.55% to -$137000.0 in 2025.
  • Business Quant data shows EQ's Net Equity Issued and Repurchased at -$137000.0 in Q4 2025, $900000.0 in Q3 2025, and -$54.9 million in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 49.20 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 141.90 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Equillium 249.33 Mn 249.33 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 900,000.00
Mar 31, 2025 55.00 Mn
Dec 31, 2024 69,000.00
Dec 31, 2021 19.91 Mn
Mar 31, 2021 10.00 Mn
Dec 31, 2020 -41,000.00
Sep 30, 2020 10.00 Mn
Mar 31, 2020 775,000.00